Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Ratio | 1 | 2014 | 4 | 0.430 |
Why?
|
| Cell Cycle | 3 | 2017 | 346 | 0.330 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 455 | 0.320 |
Why?
|
| Nocodazole | 1 | 2010 | 8 | 0.320 |
Why?
|
| Tubulin Modulators | 1 | 2010 | 20 | 0.310 |
Why?
|
| Quercetin | 1 | 2010 | 46 | 0.300 |
Why?
|
| Paclitaxel | 1 | 2010 | 64 | 0.300 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 134 | 0.280 |
Why?
|
| Campylobacter jejuni | 1 | 2006 | 22 | 0.250 |
Why?
|
| Food Handling | 1 | 2006 | 35 | 0.250 |
Why?
|
| Chickens | 1 | 2006 | 161 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 3 | 2004 | 216 | 0.220 |
Why?
|
| Indoles | 2 | 2017 | 187 | 0.220 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 223 | 0.210 |
Why?
|
| Bleomycin | 2 | 2000 | 20 | 0.200 |
Why?
|
| NF-kappa B | 2 | 2017 | 358 | 0.200 |
Why?
|
| Food Microbiology | 2 | 2013 | 39 | 0.190 |
Why?
|
| Food Contamination | 2 | 2013 | 57 | 0.190 |
Why?
|
| Connective Tissue | 1 | 2000 | 7 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2000 | 78 | 0.160 |
Why?
|
| Fibrinolysin | 1 | 1999 | 9 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2000 | 63 | 0.160 |
Why?
|
| Macrophages, Alveolar | 1 | 1999 | 34 | 0.150 |
Why?
|
| Thrombospondin 1 | 1 | 1999 | 23 | 0.150 |
Why?
|
| Neoplasms | 1 | 2010 | 1377 | 0.140 |
Why?
|
| Camptothecin | 1 | 2017 | 21 | 0.140 |
Why?
|
| Cell Death | 1 | 2017 | 278 | 0.130 |
Why?
|
| DNA, Bacterial | 2 | 2013 | 206 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 384 | 0.120 |
Why?
|
| Inflammation | 1 | 2000 | 758 | 0.110 |
Why?
|
| Insemination, Artificial | 1 | 2014 | 10 | 0.110 |
Why?
|
| Ethiopia | 1 | 2014 | 16 | 0.110 |
Why?
|
| Breeding | 1 | 2014 | 28 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1455 | 0.100 |
Why?
|
| Bacteria, Aerobic | 1 | 2013 | 7 | 0.100 |
Why?
|
| Meat Products | 1 | 2013 | 5 | 0.100 |
Why?
|
| Apoptosis | 3 | 2017 | 1568 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 611 | 0.100 |
Why?
|
| Cattle | 1 | 2014 | 498 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 587 | 0.090 |
Why?
|
| Cell Survival | 2 | 2010 | 945 | 0.090 |
Why?
|
| Animals | 6 | 2015 | 16992 | 0.090 |
Why?
|
| Ruta | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2676 | 0.080 |
Why?
|
| Time Factors | 2 | 2017 | 1857 | 0.080 |
Why?
|
| Food-Drug Interactions | 1 | 2010 | 4 | 0.080 |
Why?
|
| Cyclin B1 | 1 | 2010 | 18 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 52 | 0.080 |
Why?
|
| G2 Phase | 1 | 2010 | 28 | 0.080 |
Why?
|
| Tubulin | 1 | 2010 | 96 | 0.080 |
Why?
|
| Bacteria | 1 | 2012 | 293 | 0.070 |
Why?
|
| Microtubules | 1 | 2010 | 121 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2010 | 238 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 299 | 0.070 |
Why?
|
| DNA Damage | 1 | 2011 | 356 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 220 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2011 | 302 | 0.070 |
Why?
|
| Industrial Waste | 1 | 2006 | 16 | 0.060 |
Why?
|
| Computer Systems | 1 | 2006 | 19 | 0.060 |
Why?
|
| Calibration | 1 | 2006 | 63 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1019 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 211 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 508 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1766 | 0.060 |
Why?
|
| Pulmonary Fibrosis | 1 | 2004 | 38 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 49 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2011 | 883 | 0.050 |
Why?
|
| Female | 4 | 2014 | 24698 | 0.050 |
Why?
|
| DNA Primers | 2 | 2013 | 294 | 0.050 |
Why?
|
| Rats | 2 | 2000 | 3735 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 561 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2000 | 55 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2000 | 49 | 0.040 |
Why?
|
| Cell Count | 1 | 2000 | 145 | 0.040 |
Why?
|
| Fibronectins | 1 | 2000 | 69 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2000 | 109 | 0.040 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 1999 | 5 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 52 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 39 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 25 | 0.040 |
Why?
|
| Collagen | 1 | 2000 | 181 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2004 | 735 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1081 | 0.040 |
Why?
|
| Body Weight | 1 | 2000 | 429 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 3 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 458 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2017 | 27 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 306 | 0.030 |
Why?
|
| Humans | 5 | 2017 | 43102 | 0.030 |
Why?
|
| Caspases | 1 | 2017 | 148 | 0.030 |
Why?
|
| Lung | 1 | 2000 | 492 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 195 | 0.030 |
Why?
|
| Male | 2 | 2014 | 23409 | 0.030 |
Why?
|
| Proteins | 1 | 1999 | 382 | 0.030 |
Why?
|
| Macrophages | 1 | 2000 | 529 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 1999 | 1621 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 40 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 60 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 63 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1124 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2013 | 23 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 347 | 0.030 |
Why?
|
| Bioterrorism | 1 | 2012 | 20 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 655 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 32 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2012 | 139 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 92 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 196 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 57 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 227 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 462 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 411 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 6644 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 968 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1542 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 769 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 512 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2004 | 11 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 97 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 164 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 665 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1092 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1723 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 1869 | 0.010 |
Why?
|